Closer to the goal: Efforts in measles elimination in Germany 2010

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Siedler, Anette ^a   Mankertz, Annette ^b   Feil, Fabian ^c   Ahlemeyer, Gabriele ^e   Hornig, Angelika ^f   Kirchner, Markus ^d   Beyrer, Konrad ^d   Dreesman, Johannes ^d   Scharkus, Sibylle ^g   Marcic, Anne ^h   Reiter, Sabine ^a   Matysiak Klose, Dorothea ^a   Santibanez, Sabine ^b   Krause, Gérard ^a   Wichmann, Ole ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b National Reference Laboratory Measles   (Germany)

^c Ministry of Social Affairs   (Germany)

^d Governmental Institute of Public Health of Lower Saxony   (Germany)

^e State Institute of Health and Labour of North Rhine Westfalia   (Germany)

^f Ministry of Labor Social Affairs Health Family and Women of Rhineland Palatinate   (Germany)

^g Department for Public Health Medical Pharmaceutical and Social Affairs and Hospital Funding   (Germany)

^h Social Affairs and Health of Schleswig Holstein   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHILD CARE; DISEASE PREDISPOSITION; DRUG SURVEILLANCE PROGRAM; EPIDEMIC; GENETIC VARIABILITY; GERMANY; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFORMATION DISSEMINATION; MEASLES; MEASLES VACCINATION; MOLECULAR EPIDEMIOLOGY; MORBIDITY; NONHUMAN; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS TRANSMISSION; ADOLESCENT; CHILD; HEALTH SURVEY; INCIDENCE; INFANT; PRESCHOOL CHILD; TIME;

MEASLES VACCINE;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MEASLES; MEASLES VACCINE; MOLECULAR EPIDEMIOLOGY; POPULATION SURVEILLANCE; TIME FACTORS;

EID: 79960885424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir068     Document Type: Article

References (28)

1. Interventionsprogramm Masern-Mumps-Röteln, 1999. http://www.rki.de/cln-178/nn-199620/DE/Content/Infekt/Impfen/Praevention/ intervt.templateId=raw.property=publicationFile.pdf/intervt.pdf. Accessed 30 April 2010.
2. World Health Organization. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European region. Copenhagen: WHO Regional Office for Europe, 2009. http://www.euro.who.int/document/e93035.pdf. Accessed 30 April 2010.
3. Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K. for the EUVAC.NET group. Measles in Europe: an epidemiological assessment. Lancet 2009; 373:383-9.
4. Hellenbrand W, Siedler A, Tischer A, et al. Progress toward measles elimination in Germany. J Infect Dis 2003; 187(Suppl 1):S208-16.
5. Robert Koch-Institut. 20 jahre nach dem Fall der Mauer: wie hat sich die Gesundheit in Deutschland entwickelt? Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: RKI, 2009; 169-75.
6. Faensen D, Claus H, Benzler J, et al. Surv Net@RKI: a multistate electronic reporting system for communicable diseases. Euro Surveill 2006; 11:100-3.
7. Santibanez S, Tischer A, Heider A, Siedler A, Hengel H. Rapid replacement of endemic measles virus genotypes. J Gen Virol 2002; 83:2699-708.
8. Kremer JR, Brown KE, Jin L, et al. High genetic diversity of measles virus, World Health Organization European region, 2005-2006. Emerg Infect Dis 2008; 14:107-14.
9. Siedler A, Tischer A, Mankertz A, Santibanez S. Two outbreaks of measles in Germany, 2005. Euro Surveill 2006; 11:131-4.
10. Rota J, Lowe L, Rota P, et al. Identical genotype B3 sequences from measles patients in 4 countries, 2005. Emerg Infect Dis 2006; 12:1779-81.
11. Wichmann O, Hellenbrand W, Sagebiel D, et al. Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J 2007; 26:782-6.
12. Wichmann O, Siedler A, Sagebiel D, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ 2009; 87:108-15.
13. Lernout T, Kissling E, Hutse V, Top G. Clusters of measles cases in Jewish orthodox communities in Antwerp, epidemiologically linked to the United Kingdom: a preliminary report. Euro Surveill 2007; 12:pii53308.
14. Richard JL, Masserey Spicher V. Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe. Euro Surveill 2009; 14:pii519443.
15. Pfaff G, Mezger B, Santibanez S, et al. Measles in south-west Germany imported from Switzerland: a preliminary outbreak description. Euro Surveill 2008; 13:pii58044.
16. Wadl M, Siedler A, Krämer M, et al. Why measles outbreaks still occur in the 21st century: yet another measles outbreak in a German federal state linked to low vaccination-coverage. ECDC Eurovaccine Scientific Conference on Vaccination & Immunisation. Stockholm, 2009. http://www.congressonline. eu/ecdc/pages/home. Accessed 4 May 2010.
17. Marinova L, Muscat M, Mihneva Z, Kojouharova M. An update on an ongoing measles outbreak in Bulgaria, April-November 2009. Euro Surveill 2009; 14:pii519442.
18. Bätzing-Feigenbaum J, Pruckner U, Beyer A, et al. Spotlight on measles 2010: preliminary report of an ongoing measles outbreak in a subpopulation with low vaccination coverage in Berlin, Germany, January-March 2010. Euro Surveill 2010; 15:pii519527.
19. Robert Koch-Institut. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2008. Epidemiologisches Bull 2010; 16:137-40.
20. Oppermann H, Wahl G, Borrmann M, Fleischer J. Obligatory vaccination reporting in Saxony-Anhalt: possibilities and limitations of establishing a computerized vaccination registry [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52:1029-36.
21. World Health Organization. Measles and rubella in German-speaking countries/areas: current issues and challenges. Report of the meeting Berlin: WHO Regional Office for Europe and Robert Koch Institute, 2006. http://www.euro.who.int/en/what-we-do/health-topics/diseases-and-conditions/ measles-and-rubella/publications/pre-2009/measles-and-rubella-in-german- speaking-countriesareas-current-issues-and-challenges. Accessed 7 March 2011.
22. Schmidt-Troschke S. Impfungen aus Sicht der anthroposophischen Medizin. Public Health Forum 2009; 17:21-3.
23. Pfaff G. Reaching the hard to reach. ECDC Eurovaccine Scientific Conference on Vaccination & Immunisation. Stockholm, 2009. http://www.congressonline.eu/ecdc/pages/home. Accessed 30 April 2010.
24. Poethko-Muller C, Ellert U, Kuhnert R, Neuhauser H, Schlaud M, Schenk L. Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany. Vaccine 2009; 27:2563-9.
25. Niedersächsisches Landesgesundheitsamt. Leitfaden für das management von masernfällen. Hannover, 2007. http://www.nlga.niedersachsen. de/index.php?navigation-id56636&article-id519314-psmand520. Accessed 23 April 2010.
26. Robert Koch-Institut. Auf dem Weg zur Masernelimination bis zum Jahr 2010: Erfolge durch konsequentes Ausbruchsmanagement: Erfahrungsbericht aus Niedersachsen. Epidemiologisches Bull 2008; 07:53-5.
27. Robert Koch-Institut. Resolution des ersten Treffens der deutsch-sprachigen Staaten und Gebiete zur Eliminierung von Masern und Röteln, Berlin, 18-19. Mai 2006. Epidemiologisches Bull 2006; 22:171.
28. Reuss A, Feig M, Kappelmayer L, Eckmanns T, Poggensee G. Determination of vaccination coverage and disease incidence using statutory health insurance data [in German]. Das Gesundheitswesen 2010; 72:340-6.